Home › Peripheral Arterial Disease › Pennsylvania › Philadelphia
Peripheral Arterial Disease clinical trials in Philadelphia, PA
5 studies for Peripheral Arterial Disease are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Clinical Renal Associates, LTD, Exton · 25 mi away
The THOR IDE Study
Recruiting
- Hospital of the University of Pennsylvania, Philadelphia
- Lankenau Institute for Medical Research, Wynnewood · 7 mi away
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
Recruiting
- University of Pennsylvania, Philadelphia
Serranator POINT FORCE Registry
RecruitingObservational study
- Jefferson Einstein, Philadelphia
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
Recruiting
- University of Pennsylvania, Philadelphia
About Peripheral Arterial Disease
Peripheral arterial disease (PAD) happens when there is a narrowing of the blood vessels outside of your heart. Learn about symptoms and treatment.
More about Peripheral Arterial Disease on MedlinePlus
Peripheral Arterial Disease trials in other cities
- Cleveland, OH9 studies
- Boston, MA9 studies
- Chicago, IL9 studies
- Dallas, TX8 studies
- Houston, TX8 studies
- Gainesville, FL7 studies
- Omaha, NE7 studies
- Aurora, CO6 studies
- Nashville, TN6 studies
- Minneapolis, MN6 studies
- Miami, FL6 studies
- Atlanta, GA5 studies
Other studies in Philadelphia
- Cancer (all types)60 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Prostate Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer29 studies
- Pancreatic Cancer26 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.